- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04398277
A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic
A Daily Coping Toolkit for Medical Personnel and First-Responders During the COVID-19 Pandemic
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
During times of persistent high levels of stress, many individuals experience depletion in psychological resources, suffering intense distress that can make daily occupational and interpersonal functioning difficult. In order to assist during this exceptionally challenging crisis, this research team has developed a brief daily intervention based on decades of stress and trauma research that may help to support psychological health and coping resources in individuals on the frontlines: medical personnel and first-responders. These are individuals who are most essential to society in this difficult time. Although hospitals, fire, and police departments have existing support resources in place, they are either based on traditional models of treatment or consist of online peer-support or wellness applications. All facets of existing support/interventions have considerable utility, but it is not clear that these resources are designed to address the frequent and ongoing coping demands of this crisis across a broad swath of individuals. In particular, traditional psychotherapy models are unlikely to be successful due to very real time constraints of this population at this time. Moreover, several decades of research would argue that traditional psychotherapy is unlikely to be needed by most individuals, given prototypical patterns of adjustment across a range of aversive events, including prior pandemics (SARS: Bonanno, et al 2008). However, even resilient individuals will struggle with distress and some symptoms. Prior research has suggested that specific emotion processing patterns can support resilient outcomes over the long-term and thus frontline workers may benefit from an intervention that leverages this existing knowledge to facilitate adaptive emotion regulatory processing and elevate well-being during this crisis.
The proposed project aims to investigate a novel intervention: A Daily Coping Toolkit, administered via online application, that consists of 3 activities targeting adaptive emotional attention and expression, administered one time each day, only 4-10 minutes in duration daily. The Toolkit is both practically feasible given the demands and current burden on the target population as well as highly consistent with existing evidence. Moreover, the Toolkit is not likely to conflict with other online tools or with traditional psychotherapy and hence, can be practically applied across a broad swath of individuals in need. The primary project aim is to test the Daily Coping Toolkit on a broader population of medical personnel and first responders to determine efficacy over time, to test relative dosing, and to explicate the underlying therapeutic processes. The potential impact of this research will be evidence to support the further use of this novel tool to assist essential front-line personnel during this ongoing crisis. This may assist with mitigating the psychological toll of this crisis and also support the occupational functioning of medical personnel and first responders, thus, contributing indirectly to improved patient outcomes. Finally, knowledge gained from this research will support the further development of this tool to support individuals facing future challenging events and circumstances.
Participants: n=1000 medical personnel and first responders to test the efficacy of the Daily Coping Toolkit.
Procedure: Interested individuals will go to www.tinyurl.com/dailycopingtoolkit for additional information, including the informed consent. Once consent is provided, individuals complete a brief assessment of current symptoms, well-being and psychiatric/treatment history and then receive instructions to download the research application ExpiWell (www.expiwell.com) a secure platform that operates on ios/Android devices upon which we administer the Toolkit. Once downloaded, participants are randomized to a high versus low treatment condition and will receive daily prompts to complete the intervention. After 7 days, they complete a brief assessment of symptoms, well-being, and acceptability of the intervention and consent again for continuation in the research. Individuals can continue to use the application without consenting further if they choose and their data will not be accessible to researchers. For those that do consent, follow-up assessments occur at 2,6, and 9 months (symptoms and well-being).
Daily Coping Toolkit Intervention: Participants are prompted one time daily (with 1-2 reminders) to complete the intervention which consists of the following three parts. Randomization to high versus low condition is maintained for the first 7 days only in order to test for relative dose effects (see #3 below).
- Emotion Labelling Activity: Participants rate 10 discrete negative and positive emotional words on a likert scale (0-4). Precise labelling of emotional experience can serve as a form of implicit emotion regulation and has been associated with healthy psychophysiological and behavioral adaptation in a range of community and clinical samples
- Expressive Writing and Self Distancing Activity: Participants respond to an open-ended prompt to write about their day in an open text box in response to the prompt: "What was today like...?" After this is completed, they are prompted that if the experience was very challenging, to revisit that experience in their mind by taking a "fly on the wall" perspective (Kross & Ayduk, 2016; see figure for instructions). Persistent evidence has indicated that expressive writing is an effective coping tool. In addition, research has identified the ways in which specific word use can facilitate healthy emotional processing during stress. There is also significant research demonstrating that shifting perspective about negative emotional experiences can facilitate a healthier distance from it.
- Positive Emotion Generation Activity (1 v. 2 prompts) Participants are prompted to take a deep breath and then respond to 1 (or 2) of 8 possible prompts in which they can generate positive emotions. In response to each, they are asked to describe their thoughts or memories in open-ended text box. Note: For the first 7 days, participants are randomized to either respond to one (low dose) or two (high dose) prompts so as to test the relative efficacy of the "dose". After 8 days, all participants default to the higher dose of 2 prompts. Prompts are designed to elicit gratitude, positive social experiences, amusing memories, kind acts they committed, satisfaction/pride with accomplishments, positive future focus, and love for close others. Prior research has demonstrated that positive emotions generated during highly stressful events predict resilience and improved emotion regulation and coping. Moreover, positive emotion generation has been shown broadly to predict increased psychological wellbeing.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karin Coifman, PhD
- Phone Number: 13306729155
- Email: kcoifman@kent.edu
Study Locations
-
-
Ohio
-
Akron, Ohio, United States, 44313
- Recruiting
- Akron Children's Hospital
-
Contact:
- Sarah Delahanty, PhD
- Email: sdelahanty@akronchildrens.org
-
Akron, Ohio, United States, 44313
- Recruiting
- Summa Health Systems
-
Contact:
- Patrick Palmieri, PhD
- Email: pamierp@summahealth.org
-
Kent, Ohio, United States, 44242
- Recruiting
- Kent State University
-
Contact:
- Karin Coifman, PhD
- Phone Number: 330-672-9155
- Email: kcoifman@kent.edu
-
Contact:
- David Disabato, PhD
- Phone Number: 330-672-2184
- Email: ddisabat@kent.edu
-
Sub-Investigator:
- Stanley Seah, MA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Active Medical Personnel or First-Responders working during the COVID-19 Pandemic -
Exclusion Criteria: NONE
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Initial Low dose
Participants will receive only one daily positive emotion prompt in the first seven days of the toolkit use.
|
|
ACTIVE_COMPARATOR: Initial high dose
Participants will receive two daily positive emotion prompts in the first seven days of use.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire - 4
Time Frame: 1 week
|
Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
|
1 week
|
Patient Health Questionnaire - 4
Time Frame: 9 weeks
|
Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
|
9 weeks
|
Patient Health Questionnaire - 4
Time Frame: 26 weeks
|
Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
|
26 weeks
|
Patient Health Questionnaire - 4
Time Frame: 40 weeks
|
Patient Health Questionnaire 4 items, Kroenke, Spitzer, Williams & Lowe, 2009
|
40 weeks
|
World Health Organization Well Being Questionnaire
Time Frame: 1 week
|
2 items from the WHO-5: Beck 2004
|
1 week
|
World Health Organization Well Being Questionnaire
Time Frame: 9 weeks
|
2 items from the WHO-5: Beck 2004
|
9 weeks
|
World Health Organization Well Being Questionnaire
Time Frame: 26 weeks
|
2 items from the WHO-5: Beck 2004
|
26 weeks
|
World Health Organization Well Being Questionnaire
Time Frame: 40 weeks
|
2 items from the WHO-5: Beck 2004
|
40 weeks
|
Affective Experience
Time Frame: 1 week
|
Reported negative and positive emotions: Coifman et al, 2016
|
1 week
|
Treatment Acceptability Questionnaire
Time Frame: 1 week
|
Adapted from Hunsley, 1992, assessed subjective experience with intervention
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Doug Delahanty, PhD, Kent State University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-183
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Stress
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Baylor UniversityCompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
Institut de Recherche Biomedicale des ArmeesCompletedPsychological Stresses
-
University of California, San FranciscoNational Institute on Aging (NIA); Penn State University; Harvard UniversityCompletedStress | Depressive Symptoms | Psychological Distress | Psychological Stress | Signs and Symptoms | Psychological | Child MaltreatmentUnited States
-
Penn State UniversityStony Brook University; National Institute on Aging (NIA); Oregon State University and other collaboratorsCompleted
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
Clinical Trials on Daily Coping Toolkit
-
University of MichiganCompletedWomen With BRCA 1 or BRCA 2 Mutation | Non-tested Female Family MembersUnited States
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital,... and other collaboratorsCompleted
-
University of TorontoUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; McMaster... and other collaboratorsCompleted
-
Yale UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA); Trinity...CompletedDiabetes Mellitus | DiabetesUnited States
-
Cameroon Coalition Against Malaria (CCAM)Unknown
-
Sunnybrook Health Sciences CentreUnity Health Toronto; Institute for Clinical Evaluative SciencesCompletedCardiovascular Disease | Diabetes MellitusCanada
-
Arizona State UniversityNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety | Coping Skills | Emotional ProblemUnited States
-
Massachusetts General HospitalRecruitingSuicideUnited States
-
University of MichiganThe Craig H. Neilsen FoundationRecruitingSpinal Cord InjuriesUnited States
-
Children's Hospital Los AngelesUniversity of Southern CaliforniaCompleted